Alnara Pharmaceuticals' Series B Round

Alnara Pharmaceuticals raised a round of funding on January 08, 2010.

Alnara Pharmaceuticals is dedicated to developing and commercializing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effecti…

Articles about Alnara Pharmaceuticals' Series B Round: